baber/WOPTO huggingface dataset:
Patent EP-1384889-A2 (EP)
Inventor: OTA MASAKI
IPC: F04B27/08
Filed: 1995-10-10
Abstract: The present invention relates to a displaceable compressor
including a suction chamber (13-1), a crank chamber (12-1)
and a discharge chamber (13-2), the suction chamber (13-1)
and the discharge chamber (13-2) being connectable with
each other by way of an external refrigeration fluid
passage (40) which has external refrigeration circuit
elements (41, 42, 43), wherein the fluid circulating in the
refrigeration fluid passage (40) changes pressure thereof,
the compressor comprises a pressure supply passage (37)
communicating the discharge chamber (13-2) with the crank
chamber (12-1) to supply discharge pressure in the
discharge chamber (13-2) to the crank chamber (12-1); a
pressure release passage (35) formed inside a rotary shaft,
the pressure release passage being open to the crank
chamber; a restriction passage (36) communicated with the
pressure release passage and opened to the suction chamber,
wherein the refrigerant gas inside the crank chamber flows
out to the suction chamber through the pressure release
passage and the restriction passage; a mechanism (46, 49,
69, 73) disposed in an area communicable with the external
refrigeration fluid passage (40) to selectively and
gradually open and close the external refrigeration fluid
passage (40) in accordance with a difference between the
pressures of two points respectively positioned upstream
and downstream the area, and a valve element (38) disposed
in the pressure supply passage for actuating the mechanism
(46, 49, 69, 73), the valve element opening the pressure
supply passage to minimize the compressor displacement
thereby closing the external refrigeration fluid passage
(40) when the pressure difference is smaller than a
predetermined value.
Patent EP-1426535-A2 (EP)
Inventor: ELSNER SASCHA
IPC: E05F5/02
Filed: 2003-11-20
Abstract: The damping and slide guide (1) for a sliding door (13) has a power storage spring (2) to store closure energy when the door is closed, and a movement damper (3). The damper and spring are mounted in a  common elongate housing (4) which is mounted on the door or rail by a carrier (6). The spring and damper have a common shaft (5).
Patent EP-1426539-A2 (EP)
Inventor: LEHRHUBER KONRAD DIPL-ING
IPC: E06B1/62
Filed: 2003-12-05
Abstract: The profiled closure bar (17), for the transit between a window or door frame (10) and the building wall (11), is colored to indicate its characteristics and ensure that the correct bar is selected for fitting according to the application. The bar has a foam strip (22), to lie against the frame, with the same color as the profile bar, or with an additional color. The colors indicate the temperature behavior, fire resistance, suitability for recycling, weather resistance, or diffusion resistance. The foam strip is held in place and shrouded by a profile lip or an elastic mass (25).
Patent EP-1405913-A2 (EP)
Inventor: BARTON BARRY
IPC: A61K45/00
Filed: 1998-02-02
Abstract: Novel bacterial genes, microorganisms and processes for improving the manufacture
of 5R clavams, eg. clavulanic acid.
Patent EP-1371524-A2 (EP)
Inventor: PAQUET BERT J F
IPC: F02D41/06
Filed: 2003-06-05
Abstract: The present invention relates to a method and
apparatus for a vehicle control system comprising
electronic modules (101-109, 201, 202) used for the
automatic control of vehicle operation. The method for
automatic storing of configuration file data of at least
three electronic modules (101-109, 201, 202) for the
automatic control of vehicle operation, the electronic
modules (101-109, 201, 202) being coupled in a network
(300), comprises the steps of, at start-up of the vehicle:
     collecting automatically a value of a parameter stored
in the electronic modules (101-109, 201, 202),   deciding which of the collected values should be
maintained as being a correct value of the parameter,   sending and/or storing the correct value of the
parameter to electronic modules (101-109, 201, 202)
which did not send this value for the parameter during
the collection step.   
     A corresponding device is also provided.
Patent EP-1333561-A2 (EP)
Inventor: DENTON DARIN
IPC: H02K1/32
Filed: 2003-01-20
Abstract: A brushless permanent magnet electric motor or generator having a hollow rotor, is
provided with apertures in ends of the rotor. The apertures allow air to flow through the
center of the hollow rotor and remove heat from the rotor. Vanes or blades can be fixed to
the shaft within the rotor or fixed to ends of the rotor to force air through an interior of the
hollow rotor. Ends of the rotor can be shaped to form fan blades that draw air through the
interior of the rotor. Air flowing through the rotor can be recirculated by flowing back
through passageways formed between the stator and the motor/generator casing, through
passages through the stator, and/or back through an air gap between the stator and the
rotor.
Patent EP-1355185-A2 (EP)
Inventor: PINCIARO BRYAN D
IPC: G02C7/04
Filed: 2003-04-17
Abstract: A colored/tinted contact lens preview device which is a beauty mirror sales aid to enable
a prospective purchaser or wearer of colored or tinted contact lenses to preview the
appearance of different color or tint patterns of contact lenses as they would appear as a
colored or contact lens on the eye of the person. The preview device comprises a
transparent substrate with a selection of different color or tint circular or annular/toroidal
patterns, each of which simulates a contact lens with that particular color or tint pattern.
In usage, a person views their eye in a mirror with a particular color or tint pattern of
interest superimposed over the eye, such that the preview device simulates the
appearance of that particular color or tint contact lens on the eye of the person.
Patent EP-1357311-A2 (EP)
Inventor: OHE TAKAYUKI
IPC: C09K3/14
Filed: 2003-04-24
Abstract: A non-asbestos friction material is made by molding
and curing a composition primarily comprising a fibrous base
excluding asbestos, a binder, a filler, and at least three
metal sulfides excluding titanium sulfide, complex metal
sulfides and being free of antimony and lead compounds. This
friction material has minimized metal catch and improved wear
resistance, both in the high-temperature region. Absent lead
and antimony compounds, the friction material is friendly to
the environment.
Patent EP-1403213-A2 (EP)
Title: Floating entrance guard for preventing electrical short circuits
Inventor: MILLER DAVID
IPC: B81B7/00
Filed: 2003-09-29
Abstract: Method and apparatuses are provided for protecting an interconnect line (216) in a microelectromechanical system. The interconnect line (216) is disposed over a substrate for conducting electrical signals, such as from a bonding pad (204) to a mechanical component to effect movement as desired of the mechanical component. A first protective covering (208) is disposed over a first portion of the interconnect line and a second protective covering (212) is disposed over a second portion of the interconnect line. The first protective covering (208) is provided in electrical communication with the substrate and the second protective covering is electrically isolated from the substrate.
Patent EP-1354821-A2 (EP)
Inventor: HERVE PIERRE
IPC: B65D85/62
Filed: 2003-04-15
Abstract: The procedure consists of fastening the shingles (2) with straps (9) after stacking on top of one another to make bundles (1) with a width equivalent to the width of one shingle but with staggered ends. The shingles are stacked with their thinner ends towards the centre of the bundle for protection of the shingles, and the projecting length (7) of the staggered ends is between one sixth and one half of a shingle length (5, 6).
Patent EP-1463705-A2 (EP)
Inventor: PICARD WAYNE DAVID
IPC: C08F16/06
Filed: 2003-01-07
Abstract: The present invention is directed to using methyl acetate from a vinyl acetate-based or a vinyl- or ethylene-alcohol based polymer or copolymer process directly for use in a methanol carbonylation production process to produce acetic acid, acetic anhydride, or a coproduction of each. Methyl acetate is a by-product of commercial polyvinyl-alcohol or alkene vinyl alcohol copolymer-based processes. Generally, this material is processed to recover methanol and acetic acid. Discussed herein is a cost-saving scheme to by-pass the methyl acetate processing at production or plant facilities and utilize the methyl acetate in an integrated methanol carbonylation unit. The scheme discussed eliminates an expensive hydrolysis step often associated with the polymer process.
Patent EP-1477031-A2 (EP)
Inventor: SARKKINEN SINIKKA
IPC: H04L12/56
Filed: 2003-02-19
Abstract: The present invention is related to a method and system for multicast service announcement in a cell that includes a core network, a UTRAN, and one or more mobile network nodes. The UTRAN includes a RNC. The RNC continuously sends multicast service announcements in a frame over a channel such as a PICH. The frame may include a type field and an indication field where the type field contains information related to the type of information in the indication field, or the frame may include a current service announcement identification field, a next service announcement identification field, and a time offset field. The type field can be used also to separate long term scheduling announcement or service advertising frames from the multicast/broadcast data frames, or the type field can be used to separate the multicast/broadcast control frames from the multicast/broadcast data frames.
Patent EP-1487489-A2 (EP)
Inventor: WILDER RONALD
IPC: A61K31/22
Filed: 2003-03-04
Abstract: L'invention se rapporte à des procédés permettant de prévenir, traiter, gérer ou améliorer des troubles au moyen d'un antagoniste de l'intégrine αvβ3 associé à un inhibiteur de la réductase HMG-CoA et/ou un bisphosphonate. L'invention concerne également des procédés permettant de prévenir, traiter, gérer ou améliorer des troubles au moyen d'un antagoniste de l'intégrine αvβ3 associé à un inhibiteur de la réductase HMG-CoA et/ou un bisphosphonate, ainsi qu'à une autre thérapie (par ex. un autre agent ou traitement prophylactique ou thérapeutique) n'étant ou n'utilisant pas un antagoniste de l'intégrine αvβ3, un inhibiteur de la réductase HMG-CoA ou un bisphosphonate. En particulier, cette invention concerne des procédés permettant de prévenir, traiter, gérer ou améliorer des maladies inflammatoires, des troubles du système immunitaire, des troubles associés à une expression et/ou à une activité aberrante de l'intégrine αvβ3, des troubles associés à un métabolisme osseux anormal, des troubles associés à une angiogenèse aberrante et à des cancers, ou des états leur étant associés, et faisant appel à un anticorps se liant de manière immunospécifique à l'intégrine αvβ3 (par ex. le VITAXIN ®) associé à un inhibiteur de la réductase HMG-CoA et ou à un bisphosphonate, et éventuellement associé à une autre thérapie (par ex. un autre agent ou traitement prophylactique ou thérapeutique) n'étant ou n'utilisant pas un antagoniste de l'intégrine αvβ3, un inhibiteur de la réductase HMG-CoA ou un bisphosphonate. L'invention se rapporte en outre à des compositions et à des articles manufacturés utilisé(e)s pour prévenir, traiter, gérer ou améliorer des maladies inflammatoires, des troubles du système immunitaire, des troubles associés à une expression et/ou à une activité aberrante de l'intégrine αvβ3, des troubles associés à un métabolisme osseux anormal, des troubles associés à une angiogenèse aberrante et à des cancers, ou des états leur étant associés.
Patent EP-1620056-A2 (EP)
Inventor: BOND VINCENT CRAIG
IPC: A61K38/16
Filed: 2003-03-20
Abstract: The present invention provides a means of selectively killing epithelial cell carcinomas by administering a CXCR4-specific sequence of the Gp120 protein or Nef proteins or the proteins themselves (the modulators) such as that found in strains HIV-1, HIV-2, SIV, or FIV CXCR4-specific Gp 120 sequences or Nef proteins or sequences may be delivered to the mucosa or systemically. The mucosal means of application include oral, intranasal, ocular, intravaginal, rectal, and/or intraurethral administration in liquid or particulate form.
Patent EP-1503684-A2 (EP)
Inventor: LIM ROY K
IPC: A61B17/88
Filed: 2003-05-01
Abstract: Instruments and methods for inserting one or more implants to a surgical site in a patient in a surgical procedure, including minimally invasive surgical procedures are provided. The implant is mountable to the instrument in a reduced profile orientation and after insertion is manipulated with the insertion instrument to the desired orientation.
Patent EP-1502248-A2 (EP)
Inventor: QUIMPER REMI
IPC: G09B9/00
Filed: 2003-05-07
Abstract: Un appareil (15) d'apprentissage de procédure intégrée utilise un environnement en trois dimensions qui facilite l'apprentissage des systèmes et des procédures intégrées nécessaires pour faire fonctionner et mettre à jour des systèmes complexes. L'environnement tridimensionnel est créé par l'agencement d'une pluralité de surfaces d'affichage à effleurement (16, 18, 20) selon une disposition spatiale qui est similaire à la disposition spatiale des panneaux de commande/surveillance réels du système complexe. L'apprentissage des procédures intégrées est rendu possible par l'utilisation d'une simulation (48) à portée totale du système complexe. Des didacticiels (50) ou d'autres aides didactiques peuvent être utilisés en association avec le système pour améliorer l'assimilation et la mémorisation des connaissances ainsi que pour réduire le temps d'apprentissage et le recours aux instructeurs qualifiés.
Patent EP-1492452-A2 (EP)
Inventor: LEFERE PHILIPPE
IPC: A61B5/05
Filed: 2003-04-05
Abstract: L'invention concerne un système, une formulation, un ensemble et un procédé de marquage de résidus du colon, destinés à être employés dans la préparation d'un individu pour une activité prédéterminée nécessitant le marquage d'au moins certains résidus du colon dans le système digestif de manière qu'une procédure médicale et/ou diagnostique peut être réalisée sur le système digestif. De telles activités prédéterminées comprennent entre autres des criblages du colon. Dans un mode de réalisation, un régime diététique comportant des aliments à faibles résidus est coordonné avec le régime de marquage de résidus du colon avant une activité prédéterminée de manière à obtenir des selles marquées permettant la mise en oeuvre d'une procédure médicale et/ou diagnostique sur le système digestif. La présente invention concerne également un procédé consistant à administrer des quantités suffisantes de fluides et d'aliments tout en réduisant la formation de selles avant l'activité prédéterminée. Dans un autre mode de réalisation, les aliments contiennent une quantité efficace d'un agent de marquage de manière que, lorsque lesdits aliments sont consommés sur une période de temps, au moins certains résidus du colon présents dans le système digestif sont marqués suffisamment pour la mise en oeuvre d'une procédure médicale et/ou diagnostique sur le système digestif.
Patent EP-1530805-A2 (EP)
Inventor: ENDRISS AXEL
IPC: H01L41/083
Filed: 2003-05-23
Abstract: The invention relates to a piezoelectric actuator, for example for actuating a mechanical component, said actuator being provided with a structure consisting of a plurality of piezoelectric layers and inner electrodes (2, 3) which are arranged between said layers. An electrical voltage can be supplied by alternately and laterally bringing into contact the inner electrodes (2, 3) and outer electrodes (4, 5). A helical outer electrode is provided as a flexible part of the outer electrode (5), on which individual windings of the helix (5; 5a, 5b, 5c) can be brought into contact with a conductive surface (4) as the first part of the outer electrode (4, 5), in a punctiform or planiform manner.
Patent EP-1519956-A2 (EP)
Inventor: KINCH MICHAEL S
IPC: C12P21/08
Filed: 2003-05-12
Abstract: The present invention relates to methods and compositions designed for the treatment, management, or prevention of cancer, particularly, metastatic cancer. In one embodiment, the methods of the invention comprise the administration of an effective amount of an antibody that binds to EphA2 and agonizes EphA2, thereby increasing EphA2 pho 3phorylation and decreasing EphA2 levels. In other embodiments, the methods of the invention comprise the administration of an effective amount of an antibody that binds to Eph A2 and inhibits cancer cell colony formation in soft agar, inhibits tubular network fore cation in three-dimensional basement membrane or extracellular matrix preparation, preferentially binds to an EphA2 epitope that is exposed on cancer cells but not non-cancer cells, and/or has a low Koff, thereby, inhibiting tumor cell growth and/or metastasis. The invention also provides pharmaceutical compositions comprising one or more EphA2 antil)odies of the invention either alone or in combination with one or more other agents useful for cancer therapy.
Patent EP-1558564-A2 (EP)
Inventor: FERRARI MASSIMO
IPC: C07C61/08
Filed: 2003-10-01
Abstract: L'invention concerne un procédé de synthèse de chlorhydrate d'acide acétique 1-(aminomethyl)cyclohexane (chlorhydrate de Gabapentine) consistant: a) à faire réagir un mélange d'acétate d'ammonium/anhydre acétique avec de l'acide 1,1-cyclohexane-diacétique afin d'obtenir 3,3-pentaméthylène glutarimide; b) à traiter 3,3-pentamethylene glutarimide avec de l'hydroxyde de sodium dans une solution aqueuse jusqu'à la dissolution, à égoutter la solution ainsi obtenue dans un mélange d'hypochlorite de sodium/hydroxyde de sodium, qui est également aqueux, suivi de l'acidification avec de l'acide hydrochlorique afin d'obtenir de l'hydrochloride de gabapentine.
Patent EP-1578196-A2 (EP)
Inventor: FISHER PAUL B
IPC: C12N15/861
Filed: 2003-09-09
Abstract: The present invention relates to methods of treating a cancer in a subject comprising generating within one or more cancer cells of a subject an effective amount of MDA-7 and an effective amount of one or more free radicals. The present invention further relates to methods of inhibiting proliferation or promoting death in a cancer cell of a subject comprising generating within one or more cancer cells of a subject an effective amount of MDA-7 and an effective amount of one or more free radicals. Generation of an effective amount of MDA-7 can occur by administering to the cancer cell an effective amount of an mda-7 nucleic acid, MDA-7 protein, functional equivalents of either of these molecules, by upregulation of the endogenous mda-7 gene, or by stabilization of the mda-7 mRNA. Generation of one or more free radicals in a cancer cell can occur by exposing the cancer cell to an effective amount of ionizing radiation, a free radical, a generator of a free radical, a ROS, a generator of a ROS, or a disruptor of mitochondrial membrane potential.
Patent EP-1534345-A2 (EP)
Inventor: MITRANI EDUARDO N
IPC: A61K35/36
Filed: 2003-07-13
Abstract: A method, extract, and pharmaceutical composition for inducing angiogenesis in a tissue of a mammal, and of a device for the preparation and delivery of micro-organs into a mammal, are provided.
Patent EP-1575786-A2 (EP)
Inventor: SCHAFER RANDAL D
IPC: G01D21/00
Filed: 2003-07-17
Abstract: L'invention concerne un dispositif de mesure transparent comprenant des lignes plus visibles formées sur un substrat transparent ayant des surfaces planes avant et arrière opposées ; au moins une ligne opaque formée sur la surface avant ou la surface arrière et au moins une ligne transparente formée sur la surface avant ou arrière de manière colinéaire avec la ou les ligne(s) opaque(s) pour former une ligne composite, la ligne transparente permettant de voir le matériau sur lequel le dispositif est placé tout en faisant ressortir la ou les ligne(s) opaque(s) pour une meilleure visibilité. La ligne transparente peut être constituée de pigments excitables qui réagissent pour éclairer à la manière d'une lumière noire ou qui retiennent la luminance après exposition à la lumière.
Patent EP-1545627-A2 (EP)
Inventor: LI CHUAN-YUAN
IPC: A61K35/761
Filed: 2003-10-01
Abstract: L'invention concerne des vecteurs adénoviraux responsables de la réplication sous certaines conditions, qui confèrent une cytotoxicité sélective aux cellules exprimant HIF-1 par l'infection des cellules qui permettent de fonctionner aux promoteurs inductibles par HIF-1 présents dans les vecteurs. L'invention concerne aussi des compositions et des cellules hôtes basés sur les vecteurs ainsi que des procédés de propagation et d'utilisation des vecteurs. L'invention concerne également un procédé pour inhiber la croissance tumorale au moyen de la co-infection des cellules dans une tumeur en utilisant un vecteur d'adénovirus responsable de la réplication sous certaines conditions, conjointement avec un vecteur d'adénovirus incapable de réplication.
Patent EP-1664337-A2 (EP)
Inventor: PLOWMAN GREGORY D
IPC: C12N9/12
Filed: 2003-10-22
Abstract: L'invention concerne des gènes MBM humains, identifiés comme modulateurs de la morphogenèse ramifiée, qui constituent par conséquent des cibles thérapeutiques pour des troubles associés à une fonction déficiente de la morphogenèse ramifiée. L'invention concerne également des procédés permettant d'identifier des modulateurs de la morphogenèse ramifiée, qui consistent à cribler des agents qui modulent l'activité des MBM.
Patent EP-1579223-A2 (EP)
Inventor: LIST HANS
IPC: G01N33/487
Filed: 2003-12-22
Abstract: Die Erfindung bezieht sich auf das Gebiet von Analysesystemen, bei denen eine Probenanalyse mittels Testelemente erfolgt. Erfindungsgemäss beinhaltet das Analysesystem eine Transporteinheit, die mittels piezoaktiver Elemente angetrieben wird. Die Transporteinheit ermöglicht einen direkten oder indirekten Transport der Testelemente, so dass Analyseverfahren ganz oder teilweise automatisiert werden können. Des weiteren beinhaltet die Erfindung eine Transporteinheit zum transportieren eines Testelementes, die erfindungsgemäss über einen optischen Detektor gesteuert wird, der das Testelement im System erfasst.
Patent EP-1484950-A2 (EP)
Inventor: GERNHARDT ANGELIKA
IPC: H05K1/00
Filed: 2004-04-01
Abstract: The method involves producing the conducting tracks (5) of the circuit board (1) in a layout on a former in which the tracks are extended beyond a separation line that defines the edge that will later face the MID component (10), providing through bores (6d) along the separating line at least in the track region, electrically through-contacting (6e) the bores, separating the circuit boards from the former and positioning each circuit board to be contacted relative to the MID component and soldering adjacent tracks together. An independent claim is also included for the following: (a) a method of manufacturing more than one circuit board.
Patent EP-1491228-A2 (EP)
Inventor: SUTER BEAT
IPC: A61H23/02
Filed: 2004-06-16
Abstract: The arrangement generates sound with an electrodynamic loudspeaker (4), whereby the sound contains frequencies in the range from 2 to 20 Hz. The loudspeaker is arranged in a region of a bed in which the center of gravity of a person lying on the bed would be approximately located.
Patent EP-1464280-A2 (EP)
Inventor: SERITA EIICHI
IPC: A61B5/103
Filed: 2000-06-09
Abstract: The invention relates to a method of measuring a distribution of body fat for human
body, characterized in that it comprises the steps of:
   measuring a thickness of abdominal subcutaneous fat and a girth of abdomen;
and   calculating an area of abdominal visceral fat and/or an area of abdominal
subcutaneous fat based upon the measurements of the thickness of abdominal
subcutaneous fat and the girth of abdomen.